Tailored duration of adjuvant trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer

被引：0
|
作者：
Yu, Ke-Da [1 ]
Zhou, Zhi-Rui [1 ]
Shao, Zhi-Ming [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P3-14-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-14-04
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [1] Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancer
    Ke-Da Yu
    Xin Wang
    Wan-Kun Chen
    Lei Fan
    Miao Mo
    Han Chen
    npj Precision Oncology, 4
  • [2] Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancer
    Yu, Ke-Da
    Wang, Xin
    Chen, Wan-Kun
    Fan, Lei
    Mo, Miao
    Chen, Han
    NPJ PRECISION ONCOLOGY, 2020, 4 (01)
  • [3] Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer
    Liberato, Nicola Lucio
    Marchetti, Monia
    Barosi, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (06) : 625 - 633
  • [4] Trastuzumab: A Milestone in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Dhanushkodi, Manikandan
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (01) : 54 - 56
  • [5] Trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer
    Van den Mooter, Tom
    Teuwen, Laure-Anne
    Rutten, Annemie
    Dirix, Luc
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (05) : 749 - 760
  • [6] Trastuzumab emtansine in human epidermal growth factor receptor 2-positive breast cancer: a review
    Mathew, Jacob
    Perez, Edith A.
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (06) : 594 - 600
  • [7] The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy
    Lanning, Ryan M.
    Morrow, Monica
    Riaz, Nadeem
    McArthur, Heather L.
    Dang, Chau
    Moo, Tracy-Ann
    El-Tamer, Mahmoud
    Krause, Kate
    Siu, Chun
    Hsu, Meier
    Zhang, Zhigang
    Pei, Xin
    McCormick, Beryl
    Powell, Simon N.
    Ho, Alice
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (08) : 2517 - 2525
  • [8] Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Bines, Jose
    Procter, Marion
    Restuccia, Eleonora
    Viale, Giuseppe
    Zardavas, Dimitrios
    Suter, Thomas
    Arahmani, Amal
    Van Dooren, Veerle
    Baselga, Jose
    Clark, Emma
    Eng-Wong, Jennifer
    Gelber, Richard D.
    Piccart, Martine
    Mobus, Volker
    de Azambuja, Evandro
    CLINICAL BREAST CANCER, 2020, 20 (02) : 174 - +
  • [9] The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy
    Gopal, R.
    BREAST DISEASES, 2016, 27 (02): : 160 - 161
  • [10] The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy
    Ryan M. Lanning
    Monica Morrow
    Nadeem Riaz
    Heather L. McArthur
    Chau Dang
    Tracy-Ann Moo
    Mahmoud El-Tamer
    Kate Krause
    Chun Siu
    Meier Hsu
    Zhigang Zhang
    Xin Pei
    Beryl McCormick
    Simon N. Powell
    Alice Ho
    Annals of Surgical Oncology, 2015, 22 : 2517 - 2525
12345